PRETREATMENT WITH BETA-FUNALTREXAMINE BLOCKS MORPHINE-MEDIATED SUPPRESSION OF CTL ACTIVITY IN ALLOIMMUNIZED MICE

Citation
Gw. Carpenter et Djj. Carr, PRETREATMENT WITH BETA-FUNALTREXAMINE BLOCKS MORPHINE-MEDIATED SUPPRESSION OF CTL ACTIVITY IN ALLOIMMUNIZED MICE, Immunopharmacology, 29(2), 1995, pp. 129-140
Citations number
55
Categorie Soggetti
Pharmacology & Pharmacy",Immunology
Journal title
ISSN journal
01623109
Volume
29
Issue
2
Year of publication
1995
Pages
129 - 140
Database
ISI
SICI code
0162-3109(1995)29:2<129:PWBBMS>2.0.ZU;2-8
Abstract
The effect of prolonged exposure to morphine on cytotoxic T lymphocyte s (CTL) and splenic natural killer (NK) activity was investigated. Dai ly administration of morphine (50.0 mg/kg, s.c.) to alloimmunized mice for 11 days resulted in a significant decrease (25-50%) in peritoneal and splenic CTL activity but not splenic NK activity. To identify the effector cell population mediating cytolysis, cell enrichment studies were carried out. The results of these studies indicated the CTLs are CD8(+) CD4(-). Chronic morphine treatment increased the percentage (2 5-30%) of CD3(+) CD4(+) and CD8(+) but not Ig(+) cells in the spleen r elative to saline-treated controls. Pretreatment of mice with the mu-s elective antagonist, beta-funaltrexamine blocked morphine-mediated sup pression of splenic and peritoneal CTL activity as well as the increas e in CD3(+)CD4(+) and CD8(+) splenic lymphocytes. These results indica te the generation of CTLs in vivo is sensitive to chronic morphine exp osure implicating opiates as important co-factors through modulation o f cell-mediated immunity.